脑机接口板块，掀涨停潮

Core Viewpoint - The brain-computer interface (BCI) sector is experiencing significant activity and potential growth, driven by technological advancements and policy support, with expectations for commercialization by 2026 [1][4]. Group 1: Market Activity - On the first trading day of 2026, BCI-related stocks showed strong performance, with companies like Beiyikang and Sanbo Brain Science reaching their daily price limits [1]. - The market is expected to benefit from Neuralink's anticipated large-scale production and automated surgical solutions, which could enhance efficiency and reduce costs [1][3]. Group 2: Technological Developments - Neuralink plans to begin large-scale production of BCI devices in 2026, utilizing a new surgical method that avoids traditional invasive techniques [1][3]. - Merge Labs, co-founded by OpenAI's CEO, is focusing on non-invasive ultrasound technology to interpret brain signals without implanting electrodes [3]. Group 3: Industry Growth Projections - The global BCI market is projected to grow to approximately $12.4 billion by 2034, with a compound annual growth rate (CAGR) of 17% from 2025 to 2034 [4]. - The BCI industry is positioned for rapid expansion due to technological breakthroughs, supportive policies, and the integration of robotics [4][5]. Group 4: Competitive Landscape - The BCI field is highly competitive, with various companies engaged in clinical trials and product development across invasive, semi-invasive, and non-invasive categories [5][6]. - Domestic companies like Brain Tiger Technology are making significant advancements, while others are developing products for medical monitoring and rehabilitation [6]. Group 5: Policy and Regulatory Environment - Recent policies are clarifying standards for BCI technologies, facilitating quicker integration into healthcare systems once approved [6]. - The establishment of industry standards by the National Medical Products Administration is expected to enhance regulatory compliance and market entry for BCI products [6]. Group 6: Long-term Outlook - There is a positive long-term outlook for leading companies that possess technological and regulatory advantages, as well as those that can leverage existing resources to accelerate BCI development [7].